-+ 0.00%
-+ 0.00%
-+ 0.00%

AC IMMUNE RECEIVES FDA FAST TRACK DESIGNATION FOR ANTI-ALPHA-SYNUCLEIN ACTIVE IMMUNOTHERAPY, ACI-7104, TO TREAT EARLY PARKINSON’S DISEASE (PD)

Reuters·08/11/2026 11:00:00

Please log in to view news